Multidisciplinary Inferior Vena Cava Reconstruction for Malignancy: Outcomes of 53 Consecutive Patients and Retrospective Concordance with the 2025 Delphi Consensus

Tumours involving the inferior vena cava are rare and require complex oncovascular surgery, for which standardised recommendations have only recently been proposed. This study evaluated perioperative, oncological, and vascular outcomes of inferior vena cava resection and reconstruction in a contemporary multidisciplinary cohort and assessed its retrospective concordance with the 2025 Delphi Consensus. We retrospectively reviewed 53 consecutive patients undergoing surgery for malignant tumours involving the inferior vena cava at a tertiary referral centre between February 2009 and April 2022. Clinical, operative, postoperative, oncological, and vascular outcomes were collected from a prospectively maintained database. Vena cava reconstruction was performed in 48 patients (91%), predominantly using ringed polytetrafluoroethylene interposition grafts. Complete (R0) tumour resection was achieved in 72% of patients. R0 resection was associated with significantly better 5-year overall survival (59.0% vs. 24.0%, p = 0.006) and recurrence-free survival (57.2% vs. 15.6%, p = 0.008) compared with R1 resection. In-hospital and 90-day mortality were 3.7% and 7.5%, respectively, while 21% required urgent reintervention during the index hospitalisation. At a median follow-up of 45 months, overall survival was 78.2% at 1 year and 48.7% at 5 years. Primary venous patency was 86.0% at 1 and 2 years and 78.4% at 5 years. Surgical management showed high retrospective concordance with the Delphi Consensus recommendations, published after the study period. Inferior vena cava oncovascular resection and reconstruction can be performed with acceptable early mortality and durable venous patency in experienced multidisciplinary centres. These findings support specialised referral and provide real-world data for further standardisation of reconstruction, anticoagulation, and surveillance strategies.

Authors

Institutions

Publication Details

Journal
Current Oncology
Published
2026-11-17
DOI
https://doi.org/10.3390/curroncol33110711
Primary Topic
Vascular anomalies and interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multidisciplinary Inferior Vena Cava Reconstruction for Malignancy: Outcomes of 53 Consecutive Patients and Retrospective Concordance with the 2025 Delphi Consensus

Magalie Fau, Xavier Bérard, Caroline Caradu, Quentin Balézeaux et al.
3 links
Current Oncology
Vascular anomalies and interventions
article

Multidisciplinary Inferior Vena Cava Reconstruction for Malignancy: Outcomes of 53 Consecutive Patients and Retrospective Concordance with the 2025 Delphi Consensus

Magalie Fau, Xavier Bérard, Caroline Caradu, Quentin Balézeaux, Éric Ducasse, Quentin Toyen, Claire Webster
article en

Abstract

Tumours involving the inferior vena cava are rare and require complex oncovascular surgery, for which standardised recommendations have only recently been proposed. This study evaluated perioperative, oncological, and vascular outcomes of inferior vena cava resection and reconstruction in a contemporary multidisciplinary cohort and assessed its retrospective concordance with the 2025 Delphi Consensus. We retrospectively reviewed 53 consecutive patients undergoing surgery for malignant tumours involving the inferior vena cava at a tertiary referral centre between February 2009 and April 2022. Clinical, operative, postoperative, oncological, and vascular outcomes were collected from a prospectively maintained database. Vena cava reconstruction was performed in 48 patients (91%), predominantly using ringed polytetrafluoroethylene interposition grafts. Complete (R0) tumour resection was achieved in 72% of patients. R0 resection was associated with significantly better 5-year overall survival (59.0% vs. 24.0%, p = 0.006) and recurrence-free survival (57.2% vs. 15.6%, p = 0.008) compared with R1 resection. In-hospital and 90-day mortality were 3.7% and 7.5%, respectively, while 21% required urgent reintervention during the index hospitalisation. At a median follow-up of 45 months, overall survival was 78.2% at 1 year and 48.7% at 5 years. Primary venous patency was 86.0% at 1 and 2 years and 78.4% at 5 years. Surgical management showed high retrospective concordance with the Delphi Consensus recommendations, published after the study period. Inferior vena cava oncovascular resection and reconstruction can be performed with acceptable early mortality and durable venous patency in experienced multidisciplinary centres. These findings support specialised referral and provide real-world data for further standardisation of reconstruction, anticoagulation, and surveillance strategies.

Current OncologyVol. 33(11)
Imperial College Healthcare NHS Trust (GB), Centre Hospitalier Universitaire de Bordeaux (FR), St Mary's Hospital (GB), Hôpital Pellegrin (FR), St Mary's Hospital (GB), Institut Bergonié (FR)
Good health and well-being
Vascular anomalies and interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon